| Polydrug abuse: a review of opioid and benzodiazepine combination use JD Jones, S Mogali, SD Comer Drug and alcohol dependence 125 (1-2), 8-18, 2012 | 756 | 2012 |
| Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use JA Gudin, S Mogali, JD Jones, SD Comer Postgraduate medicine 125 (4), 115-130, 2013 | 277 | 2013 |
| Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial SL Walsh, SD Comer, MR Lofwall, B Vince, N Levy-Cooperman, D Kelsh, ... JAMA psychiatry 74 (9), 894-902, 2017 | 101 | 2017 |
| Glial and neuroinflammatory targets for treating substance use disorders RK Bachtell, JD Jones, KG Heinzerling, PM Beardsley, SD Comer Drug and alcohol dependence 180, 156-170, 2017 | 97 | 2017 |
| The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid‐dependent volunteers ZD Cooper, KW Johnson, M Pavlicova, A Glass, SK Vosburg, MA Sullivan, ... Addiction biology 21 (4), 895-903, 2016 | 90 | 2016 |
| Effects of ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence VE Metz, JD Jones, J Manubay, MA Sullivan, S Mogali, A Segoshi, ... Neuropsychopharmacology 42 (9), 1825-1832, 2017 | 72 | 2017 |
| No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone JD Jones, A Campbell, VE Metz, SD Comer Addictive behaviors 71, 104-106, 2017 | 70 | 2017 |
| The pharmacogenetics of alcohol use disorder JD Jones, SD Comer, HR Kranzler Alcoholism: Clinical and Experimental Research 39 (3), 391-402, 2015 | 70 | 2015 |
| Sex differences among opioid-abusing patients with chronic pain in a clinical trial J Manubay, J Davidson, S Vosburg, J Jones, S Comer, M Sullivan Journal of addiction medicine 9 (1), 46-52, 2015 | 65 | 2015 |
| Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users JD Jones, P Roux, S Stancliff, W Matthews, SD Comer International Journal of Drug Policy 25 (1), 166-170, 2014 | 64 | 2014 |
| Assessment of a formulation designed to be crush-resistant in prescription opioid abusers SK Vosburg, JD Jones, JM Manubay, JB Ashworth, IH Benedek, ... Drug and alcohol dependence 126 (1-2), 206-215, 2012 | 62 | 2012 |
| A review of human drug self-administration procedures JD Jones, SD Comer Behavioural pharmacology 24 (5 and 6), 384-395, 2013 | 61 | 2013 |
| Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of … P Roux, MA Sullivan, J Cohen, L Fugon, JD Jones, SK Vosburg, ... PAIN® 154 (8), 1442-1448, 2013 | 57 | 2013 |
| Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers SD Comer, S Mogali, PA Saccone, P Askalsky, D Martinez, EA Walker, ... Neuropsychopharmacology 38 (12), 2427-2438, 2013 | 54 | 2013 |
| How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies J Neale, C Brown, ANC Campbell, JD Jones, VE Metz, J Strang, ... Addiction 114 (4), 708-718, 2019 | 53 | 2019 |
| A comparison among tapentadol tamper‐resistant formulations (TRF) and OxyContin® (non‐TRF) in prescription opioid abusers SK Vosburg, JD Jones, JM Manubay, JB Ashworth, DY Shapiro, ... Addiction 108 (6), 1095-1106, 2013 | 52 | 2013 |
| Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances ZD Cooper, JD Jones, SD Comer Expert opinion on investigational drugs 21 (2), 169-178, 2012 | 52 | 2012 |
| Chronic pain and opioid abuse: Factors associated with health‐related quality of life JD Jones, JS Vogelman, R Luba, M Mumtaz, SD Comer The American journal on addictions 26 (8), 815-821, 2017 | 43 | 2017 |
| Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine‐maintained heroin users JD Jones, MA Sullivan, SK Vosburg, JM Manubay, S Mogali, V Metz, ... Addiction biology 20 (4), 784-798, 2015 | 40 | 2015 |
| A review of pharmacogenetic studies of substance-related disorders JD Jones, SD Comer Drug and alcohol dependence 152, 1-14, 2015 | 37 | 2015 |
